Vitamin C Cures Everything
Vitamin C is an essential nutrient with well-established roles in immune function and tissue repair. However, evidence does not support claims that megadose supplementation prevents or cures most diseases. A Cochrane review of 29 trials found no reduction in common cold incidence from vitamin C supplementation in the general population, though it modestly reduces cold duration.
What we know
Vitamin C (ascorbic acid) is a water-soluble vitamin essential for collagen synthesis, immune function, and antioxidant defense. Severe deficiency causes scurvy, a historical affliction of sailors. The cure-all claim derives partly from Linus Pauling's advocacy of megadose vitamin C from the 1970s onward, including his assertion that high-dose supplementation could cure or prevent cancer and the common cold. Pauling was a double Nobel laureate in chemistry and peace, lending initial credibility to claims that have not withstood scientific scrutiny.
The most comprehensive assessment of vitamin C and the common cold is a Cochrane systematic review (updated 2013) of 29 randomized controlled trials involving over 11,000 participants. It found that regular vitamin C supplementation does not reduce the incidence of colds in the general population. It does modestly reduce cold duration by about 8% in adults and 14% in children. In specific high-stress populations (marathon runners, soldiers in sub-arctic conditions), vitamin C reduced cold incidence by about half. Therapeutic doses given after cold onset showed no consistent benefit.
Regarding cancer, initial promising results from Pauling and Cameron's studies were found to be methodologically flawed. Subsequent well-designed randomized trials of oral vitamin C found no benefit for cancer. More recently, intravenous (IV) high-dose vitamin C has attracted renewed interest because IV administration achieves plasma concentrations 30–70 times higher than oral dosing, and preliminary phase 2 trials have shown promising results in specific cancer types (pancreatic cancer, glioblastoma) as an adjunct to chemotherapy — but these are early-phase studies and no phase 3 confirmation exists.
For other conditions — cardiovascular disease, pneumonia, COVID-19 — evidence from systematic reviews does not support megadose vitamin C as a treatment. At very high doses (above 2 g/day), vitamin C can cause gastrointestinal upset and, in susceptible individuals, contribute to kidney stone formation.
Common claims
- High-dose vitamin C prevents the common cold.False for general populations. A Cochrane review of 11,000+ participants found no reduction in cold incidence with regular supplementation.
- Vitamin C cures cancer.False as a standalone treatment. Early claims were methodologically flawed. IV vitamin C is under active investigation as a chemotherapy adjunct; no phase 3 evidence yet.
- You cannot take too much vitamin C because it is water-soluble and just excreted.Oversimplified. Very high doses cause gastrointestinal symptoms and increase kidney stone risk in susceptible individuals. Excess is excreted but not without effects at high dosing.
Evidence hierarchy
All sources
- Vitamin C for preventing and treating the common coldCochrane Database of Systematic Reviews · 2013
- Vitamin C supplementation for prevention and treatment of pneumoniaCochrane Database of Systematic Reviews · 2021
- High-dose vitamin C: Can it kill cancer cells?Mayo Clinic · 2023
- High-dose IV vitamin C plus chemotherapy doubles survival in advanced pancreatic cancerUniversity of Iowa Carver College of Medicine · 2024
- High-Dose Vitamin C for Cancer TherapyPharmaceuticals / PMC · 2022